M. Konopleva

Results of a Phase II Study of Crenolanib in Relapsed/Refractory Acute Myeloid Leukemia Patients (Pts) with Activating FLT3 Mutations

Jasleen K. Randhawa, Hagop M. Kantarjian, Gautam Borthakur et al. · Blood · 2014 · 112 citations

Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1

Yoko Tabe, Lin Jin, Rooha Contractor et al. · Cell Death and Differentiation · 2007 · 52 citations · Full text

Inflammation, Annexin A1, Hdac Inhibitors +12

FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cells

X Liu, Simon N. Robinson, Tetsuro Setoyama et al. · Bone Marrow Transplantation · 2014 · 41 citations · Full text

Direct Target, T-regulatory Cell, Immunology +7

Leukemia cell mobilization with G-CSF plus plerixafor during busulfan–fludarabine conditioning for allogeneic stem cell transplantation

M. Konopleva, Christopher B. Benton, Peter F. Thall et al. · Bone Marrow Transplantation · 2015 · 33 citations · Full text

Hematological Malignancy, Cell Therapy, Transplantation +13

Influence of IDH on FLT3-ITD status in newly diagnosed AML

Prajwal Boddu, Kunihiko Takahashi, Naveen Pemmaraju et al. · Leukemia · 2017 · 31 citations

Medicine, Immunology, Pathology +2